{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:00:32Z","timestamp":1773270032476,"version":"3.50.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>This study aimed to explore the therapeutic efficacy and safety of alfacalcidol among Chinese postmenopausal women (age &gt;65 years) with osteoporosis or osteopenia.<\/jats:p>\n            <jats:p>A total of 62 postmenopausal women with osteoporosis or osteopenia (&gt;65 years) were recruited from urban residential community of Beijing. The patients daily took oral calcium and alfacalcidol (Alpha D3, 1\u200a\u03bcg) for 9 months. Safety and efficacy assessments were performed at baseline and regular intervals. Alfacalcidol was adjusted to a daily dose of 0.5\u200a\u03bcg in case of hypercalcemia or hypercalciuria.<\/jats:p>\n            <jats:p>A significant improvement in \u201ctimed up and go test\u201d and \u201cchair rising test\u201d was achieved 3 months after treatment. Significant decreases in bone turnover markers were observed 3 months after the treatment and lasted throughout the study. Nineteen patients discontinued due to adverse events (17 hypercalciuria, 1 hydronephrosis, and 1 stomach ache), while alfacalcidol was adjusted to a daily dose of 0.5\u200a\u03bcg in 18 patients (29.0%). Increased serum creatinine was observed when compared to baseline (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;.001), but all the values were in normal range.<\/jats:p>\n            <jats:p>The treatment with 1\u200a\u03bcg alfacalcidol can significantly improve muscle function and bone metabolism. Regular monitoring of urine calcium and timely dosage-adjustments are very important to guarantee the safety of alfacalcidol treatment in Chinese menopausal women.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013159","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T04:27:05Z","timestamp":1542774425000},"page":"e13159","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia"],"prefix":"10.1097","volume":"97","author":[{"given":"Nan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science"},{"name":"Department of Geriatric Endocrinology, Chinese PLA General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuli","family":"He","sequence":"additional","affiliation":[{"name":"Department of Nutriology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.39428.470752.AD","article-title":"Shifting the focus in fracture prevention from osteoporosis to falls","volume":"336","author":"Jarvinen","year":"2008","journal-title":"BMJ"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF01015216","article-title":"Muscle strength and functional capacity in 78-81-year-old men and women","volume":"52","author":"Danneskiold-Samsoe","year":"1984","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"M112","DOI":"10.1093\/gerona\/53A.2.M112","article-title":"The effect of falls and fall injuries on functioning in community-dwelling older persons","volume":"53","author":"Tinetti","year":"1998","journal-title":"J Gerontol A, Biol Sci Med Sci"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2017.19344","article-title":"Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: a systematic review and meta-analysis","volume":"318","author":"Zhao","year":"2017","journal-title":"JAMA"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1185\/03007995.2011.580341","article-title":"Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT)\u201402","volume":"27","author":"Orimo","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3892\/br.2016.710","article-title":"Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors","volume":"5","author":"Asaoka","year":"2016","journal-title":"Biomed Rep"},{"key":"R9-20230914","first-page":"121","article-title":"Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial","volume":"9","author":"Jiang","year":"2014","journal-title":"Clin Interv Aging"},{"key":"R10-20230914","first-page":"1254","article-title":"Efficacy observation of alfacalcidol in the treatment of postmenopausal osteoporosis","volume":"12","author":"L","year":"2013","journal-title":"Chin J Osteoporos"},{"key":"R11-20230914","article-title":"Therapeutic effect of alfacalcidol on 56 cases of primary senile osteoporosis","volume":"34","author":"PS","year":"2013","journal-title":"Shanghai Med Pharm J"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States 2005\u20132025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ptj\/80.9.896","article-title":"Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test","volume":"80","author":"Shumway-Cook","year":"2000","journal-title":"Phys Ther"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ageing\/32.3.315","article-title":"Identifying a cut-off point for normal mobility: a comparison of the timed \u2019up and go\u2019 test in community-dwelling and institutionalised elderly women","volume":"32","author":"Bischoff","year":"2003","journal-title":"Age Ageing"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/archinternmed.2011.434","article-title":"\"\u2019Timed up and go\u2019 test and bone mineral density measurement for fracture prediction","volume":"171","author":"Zhu","year":"2011","journal-title":"Arch Intern Med"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1359\/jbmr.1999.14.9.1614","article-title":"Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study","volume":"14","author":"Garnero","year":"1999","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s002239900135","article-title":"Biochemical markers of bone turnover reflect femoral bone loss in elderly women","volume":"59","author":"Dresner-Pollak","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.1999.14.8.1404","article-title":"Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures","volume":"14","author":"Bauer","year":"1999","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s00198-005-0052-3","article-title":"Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study","volume":"17","author":"Iki","year":"2006","journal-title":"Osteoporos Int"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.2002.17.5.826","article-title":"Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study","volume":"17","author":"Garnero","year":"2002","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study","volume":"15","author":"Garnero","year":"2000","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3109\/s10165-011-0455-2","article-title":"Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort","volume":"21","author":"Yoshimura","year":"2011","journal-title":"Mod Rheumatol"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1001\/jama.291.16.1999","article-title":"Effect of vitamin D on falls: a meta-analysis","volume":"291","author":"Bischoff-Ferrari","year":"2004","journal-title":"JAMA"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1532-5415.2004.52060.x","article-title":"Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500\u200amg daily","volume":"52","author":"Dukas","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00223-008-9102-0","article-title":"Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis","volume":"82","author":"Richy","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00305521","article-title":"Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis","volume":"54","author":"Orimo","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s001980050131","article-title":"Treatment with active vitamin D metabolites and concurrent treatments in the prevention of hip fractures: a retrospective study","volume":"9","author":"Tanizawa","year":"1999","journal-title":"Osteoporos Int"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0169-6009(08)80003-7","article-title":"The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3","volume":"20","author":"Shiraki","year":"1993","journal-title":"Bone Miner"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002239900702","article-title":"Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy","volume":"65","author":"Lau","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"R31-20230914","first-page":"4","article-title":"The D-hormone analog alfacalcidol: the pioneer beyond the horizon of osteoporosis treatment","volume":"76","author":"Orimo","year":"2005","journal-title":"J Rheumatol Suppl"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ki.5002708","article-title":"24-h uric acid excretion and the risk of kidney stones","volume":"73","author":"Curhan","year":"2008","journal-title":"Kidney Int"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJM197909063011008","article-title":"Urinary calcium excretion in human beings","volume":"301","author":"Bleich","year":"1979","journal-title":"New Engl J Med"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI116246","article-title":"Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption","volume":"91","author":"Li","year":"1993","journal-title":"J Clin Invest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201811210-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T17:13:02Z","timestamp":1694711582000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201811210-00013"}},"subtitle":["An open label, non-comparative, post marketing observational study"],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":32,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013159","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}